Precision BioSciences, Inc.
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

Last updated:

Abstract:

Disclosed herein is a genetically-modified cell comprising in its genome a modified human T cell receptor alpha constant region gene, wherein the cell has reduced cell-surface expression of the endogenous T cell receptor. The present disclosure further relates to methods for producing such a genetically-modified cell, and to methods of using such a cell for treating a disease in a subject.

Status:
Grant
Type:

Utility

Filling date:

1 Mar 2021

Issue date:

8 Mar 2022